A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. (Q51867806)

14 April 2018

title

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. (English)

1 reference

14 April 2018

20

Don C Des Jarlais

1 reference

14 April 2018

David H Perlman

21

object named as

David C Perlman

1 reference

14 April 2018

Ashly E Jordan

7

object named as

Ashly E Jordan

1 reference

14 April 2018

Kevin L Delucchi

2

object named as

Kevin L Delucchi

1 reference

14 April 2018

author name string

Carmen L Masson

1

1 reference

14 April 2018

Courtney McKnight

3

1 reference

14 April 2018

Jennifer Hettema

4

1 reference

14 April 2018

Mandana Khalili

5

1 reference

14 April 2018

Albert Min

6

1 reference

14 April 2018

Nicole Pepper

8

1 reference

14 April 2018

Jessica Hall

9

1 reference

14 April 2018

Nicholas S Hengl

10

1 reference

14 April 2018

Christopher Young

11

1 reference

14 April 2018

Michael S Shopshire

12

1 reference

14 April 2018

Jennifer K Manuel

13

1 reference

14 April 2018

Lara Coffin

14

1 reference

14 April 2018

Hali Hammer

15

1 reference

14 April 2018

Bradley Shapiro

16

1 reference

14 April 2018

Randy M Seewald

17

1 reference

14 April 2018

Henry C Bodenheimer

18

1 reference

14 April 2018

James L Sorensen

19

1 reference

14 April 2018

language of work or name

English

0 references

publication date

15 August 2013

1 reference

14 April 2018

American Journal of Public Health

published in

1 reference

14 April 2018

volume

103

1 reference

14 April 2018

page(s)

e81-8

1 reference

14 April 2018

issue

10

1 reference

14 April 2018

Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis C among clients of health care for the homeless primary care clinics

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Effect of a patient navigator program on the volume and quality of colonoscopy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Injecting drug users' understanding of hepatitis C.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Limited uptake of hepatitis C treatment among injection drug users

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Evolving trends in medical care-coordination for patients with HIV and AIDS.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Patient navigation and case management following an abnormal mammogram: a randomized clinical trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Barriers to the treatment of hepatitis C. Patient, provider, and system factors

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Adherence to hepatitis B virus vaccination at syringe exchange sites

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

High Compliance with a Hepatitis B Virus Vaccination Program among Intravenous Drug Users

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

The Fifth Edition of the Addiction Severity Index

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis C virus: from discovery to eradication in 40 years?

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

HIV System Navigation: an emerging model to improve HIV care access

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

The impact of injecting drug use status on hepatitis C-related referral and treatment

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Provision of on-site medical care to patients with hepatitis C in drug treatment units.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Case management for substance abusers with HIV/AIDS: a randomized clinical trial

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Multiple modes of hepatitis A virus transmission among methamphetamine users.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853128

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

13 August 2018

1 reference

12 December 2020

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

1 reference

12 December 2020

Knowledge of hepatitis among active drug injectors at a syringe exchange program

1 reference

12 December 2020

Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program

1 reference

12 December 2020

Providing medical care to methadone clinic patients: referral vs on-site care

1 reference

12 December 2020

Identifiers

DOI

10.2105/AJPH.2013.301458

1 reference

14 April 2018

PMCID

3853128

1 reference

14 April 2018

PubMed ID

23947319

1 reference

14 April 2018